References
- GregoriadisGEnzyme-carrier potential of liposomes in enzyme replacement therapyN Engl J Med197529242151109221
- GregoriadisGHoming of liposomes to target cellsBiochem Soc Trans19753561361853164
- GregoriadisGNeerunjunEDTreatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survivalRes Commun Chem Pathol Pharmacol19751023513621153840
- SegalAWGregoriadisGBlackCDLiposomes as vehicles for the local release of drugsClin Sci Mol Med1975492991061149407
- SinghMChakrapaniAO’HaganDNanoparticles and microparticles as vaccine-delivery systemsExpert Rev Vaccines20076579780817931159
- Lövgren BengtssonKMoreinBOsterhausADISCOM technology-based Matrix MTM adjuvant: success in future vaccines relies on formulationExpert Rev Vaccines201110440140321506635
- SunHXXieYYeYPISCOMs and ISCOMATRIXVaccine200927334388440119450632
- BjörkmanCLundénAHolmdahlJBarberJTreesAJUgglaANeospora caninum in dogs: detection of antibodies by ELISA using an iscom antigenParasite Immunol199416126436487708430
- ChanlunAEmanuelsonUAiumlamaiSBjörkmanCVariations of Neospora caninum antibody levels in milk during lactation in dairy cowsVet Parasitol20061413–434935516842923
- LövgrenKMoreinBThe requirement of lipids for the formation of immunostimulating complexes (iscoms)Biotechnol Appl Biochem19881021611722838046
- SlotvedHCJensenLLindPComparison of the IFAT and Iscom-ELISA response in bovine foetuses with Neospora caninum infectionInt J Parasitol19992981165117410576568
- MoreinBSundquistBHöglundSDalsgaardKOsterhausAIscom, a novel structure for antigenic presentation of membrane proteins from enveloped virusesNature198430859584574606709052
- PandeyRSBabbarAKKaulAMishraAKDixitVKEvaluation of ISCOM matrices clearance from rabbit nasal cavity by gamma scintigraphyInt J Pharm20103981523123620688140
- Solano-ParadaJGonzalez-GonzalezGTorróLMEffectiveness of intranasal vaccination against Angiostrongylus costaricensis using a serine/threonine phosphatase 2 A synthetic peptide and recombinant antigensVaccine201028325185519620558243
- KodamaSHiranoTNodaKUmemotoSSuzukiMNasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific longterm mucosal immune responses in the nasopharynxVaccine201129101881189021237276
- BjörkmanCJakubekEBArnemoJMMalmstenJSeroprevalence of Neospora caninum in gray wolves in ScandinaviaVet Parasitol20101731–213914220609524
- FrösslingJBonnettBLindbergABjörkmanCValidation of a Neospora caninum iscom ELISA without a gold standardPrev Vet Med200357314115312581597
- MalmstenJJakubekE-BBjörkmanCPrevalence of antibodies against Toxoplasma gondii and Neospora caninum in moose (Alces alces) and roe deer (Capreolus capreolus) in SwedenVet Parasitol20111773–427528021232869
- KensilCRSaponins as vaccine adjuvantsCrit Rev Ther Drug Carrier Syst1996131–21558853958
- KerstenGFSpiekstraABeuveryECCrommelinDJOn the structure of immune-stimulating saponin-lipid complexes (iscoms)Biochim Biophys Acta1991106221651712004105
- KerstenGFTeerlinkTDerksHJIncorporation of the major outer membrane protein of Neisseriagonorrhoeae in saponin-lipid complexes (iscoms): chemical analysis, some structural features, and comparison of their immunogenicity with three other antigen delivery systemsInfect Immun19885624324383123391
- AkerblomLNaraPDunlopNPutneySMoreinBHIV experimental vaccines based on the iscom technology using envelope and GAG gene productsBiotechnol Ther199343–41451618292967
- HeegKKuonWWagnerHVaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptideEur J Immunol1991216152315271904363
- SjölanderSHansenJELövgren-BengtssonKAkerblomLMoreinBInduction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systemsVaccine19961443443528744563
- MowatAMDonachieAMReidGJarrettOImmune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral routeImmunology19917233173222026440
- MeadowsDCGervay-HagueJVinyl sulfones: synthetic preparations and medicinal chemistry applicationsMed Res Rev200626679381416788979
- SimpkinsNSThe chemistry of vinyl sulphonesTetrahedron1990462069516984
- Lopez JaramilloFHernandez MateoFSantoyo GonzalezFVinyl sulfone: a multi-purpose function in proteomicsEastwood LeungH-CIntegrative ProteomicsCroatiaInTech2012301326
- Morales-SanfrutosJLopez-JaramilloJOrtega-MunozMVinyl sulfone: a versatile function for simple bioconjugation and immobilizationOrg Biomol Chem20108366767520090986
- SaradaRPillaiMGRavishankarGAPhycocyanin from Spirulina sp: influence of processing of biomass on phycocyanin yield, analysis of efficacy of extraction methods and stability studies on phycocyaninProcess Biochemistry1999348795801
- Morales-SanfrutosJMegia-FernandezAHernandez-MateoFGiron-GonzalezMDSalto-GonzalezRSantoyo-GonzalezFAlkyl sulfonyl derivatized PAMAM-G2 dendrimers as nonviral gene delivery vectors with improved transfection efficienciesOrg Biomol Chem20119385186421120228
- RönnbergBFekaduMMoreinBAdjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrixVaccine19951314137513828585296
- PapadopoulouGKaragouniEDotsikaEISCOMs vaccine against experimental leishmaniasisVaccine1998169–108858929682333
- MyschikJLendemansDGMcBurneyWTDemanaPHHookSRadesTOn the preparation, microscopic investigation and application of ISCOMsMicron200637872473416750912
- Ruiz-PerezLMOsunaALopezMCActivity of rhodium(III) complexes against Trypanosoma cruziArzneimittelforschung19883823123142453194
- BradfordMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem197672248254942051
- De PablosLMGonzálezGGSolano ParadaJDifferential Expression and Characterization of a Member of the Mucin-Associated Surface Protein Family Secreted by TrypanosomacruziInfect Immun201179103993400121788387
- CoeJECoePRRossMJStaphylococcal protein A purification of rodent IgG1 and IgG2 with particular emphasis on syrian hamstersMol Immunol19811811100710127043241
- GrailleMSturaEACorperALCrystal structure of a Staphylococcusaureus protein A domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activityProc Natl Acad Sci U S A200097105399540410805799
- ShpigelEGoldlustAEshelAExpression, purification and applications of staphylococcal protein A fused to cellulose-binding domainBiotechnol Appl Biochem200031Pt 319720310814589
- GussBUhlénMNilssonBLindbergMSjöquistJSjödahlJRegion X, the cell-wall-attachment part of staphylococcal protein AEur J Biochem198413824134206697996
- UhlénMGussBNilssonBGatenbeckSPhilipsonLLindbergMComplete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplicationsJ Biol Chem19842593169517026319407
- HarbersEMuellerWOn the inhibition of RNA synthesis by actinomycinBiochem Biophys Res Commun1962710711013904561
- WaksmanSAGeigerWBReynoldsDMStrain Specificity and Production of Antibiotic Substances: VII. Production of Actinomycin by Different ActinomycetesProc Natl Acad Sci U S A194632511712016588723
- FernandesJFHalsmanMCastellaniOEffect of actinomycin D on the infectivity of Trypanosoma cruziNature19652075000100410055886922
- GentilLGCorderoEMdo CarmoMSdos SantosMRda SilveiraJFPosttranscriptional mechanisms involved in the control of expression of the stage-specific GP82 surface glycoprotein in Trypanosoma cruziActa Trop2009109215215819013421
- KerrIDLeeJHFaradyCJVinyl sulfones as antiparasitic agents and a structural basis for drug designJ Biol Chem200928438256972570319620707
- StormGBelliotSODaemenTLasicDDSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte systemAdv Drug Deliv Rev19951713148